Revenues |
2,319.2 |
13.4 |
Profits |
403.9 |
7.1 |
Assets |
2,850.5 |
|
Stockholders' Equity |
1,566.9 |
|
Market Value 3/17/2006 |
15,461.3 |
|
Revenues |
17.4 |
Assets |
14.2 |
Stockholders' equity |
25.8 |
|
2005 $ |
3.01 |
% change from 2004 |
6.7 |
1995-2005 annual growth rate % |
18.3 |
|
2005 |
33.8 |
1995-2005 annual rate |
22.2 |
Industry: Pharmaceuticals |
1 |
Pfizer
|
31 |
51,353.0 |
2 |
Johnson & Johnson
|
32 |
50,514.0 |
3 |
Abbott Laboratories
|
93 |
22,337.8 |
4 |
Merck
|
95 |
22,011.9 |
5 |
Bristol-Myers Squibb
|
110 |
20,222.0 |
6 |
Wyeth
|
119 |
18,755.8 |
7 |
Eli Lilly
|
148 |
14,645.3 |
8 |
Amgen
|
181 |
12,430.0 |
9 |
Schering-Plough
|
250 |
9,508.0 |
10 |
Forest Laboratories
|
588 |
3,159.6 |
11 |
Genzyme
|
643 |
2,734.8 |
12 |
Hospira
|
660 |
2,626.7 |
13 |
Biogen Idec
|
706 |
2,422.5 |
14 |
Allergan
|
734 |
2,319.2 |
15 |
Gilead Sciences
|
801 |
2,028.4 |
16 |
Chiron
|
828 |
1,919.7 |
17 |
King Pharmaceuticals
|
865 |
1,774.7 |
18 |
NBTY
|
880 |
1,737.2 |
19 |
Watson Pharmaceuticals
|
917 |
1,646.2 |
From the April 17th, 2006 issue
|
Most profitable companies |
Women CEOs of FORTUNE 500 companies |
There are more women running FORTUNE 500 companies this year than there were last year. Currently, 10 FORTUNE 500 companies are run by women (up from 9 last year), and a total of 20 FORTUNE 1000 companies have women in the top job (up from 19). (more) |
|